Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Time to Thrombocytic Inhibition After Supine and Upright Ingestion of Efient

This study has been completed.
Information provided by (Responsible Party):
Jacob Antonsen, Rigshospitalet, Denmark Identifier:
First received: December 21, 2010
Last updated: April 9, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2016
  Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)